Zoek op de hele website

Vind trainingen, blogposts, richtlijnen, kennisbankartikelen en meer.

om te navigeren esc om te sluiten om te openen
GMP + GDP Concept

Annex 15 - Qualification and Validation

This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II.

Organisaties:
EMA
Onderwerpen:
Qualification & Validation

Versietijdlijn

Chronologische releasegeschiedenis

EMA/INS/GMP/20217/2026

Versiemijlpaal

Concept

Publicatiedatum

19 jan 2026

guidelines.detail.timeline.expected_date

1 dec 2026

Belangrijkste updates: Annex 15 will become mandatory for active substances manufacturers, an enhanced focus on robust process development and clarification on the concurrent validation approach. More emphasis on QRM in design and qualification activities.

Ares(2015)1380025 - 30/03/2015

Versiemijlpaal

Publicatiedatum

30 mrt 2015

Ingangsdatum

1 okt 2015